Thaçi, D., Vender, R., de Rie, M., Conrad, C., Soung, J., Strober, B., Wang, M., Cross, N., Deherder, D., Gomez, N. N., & Gottlieb, A. B. (2022). Bimekizumab efficacy and safety through three years in patients with moderate to severe plaque psoriasis: Long-term results from the BE SURE randomized controlled trial and the BE BRIGHT open-label extension. SKIN The Journal of Cutaneous Medicine, 6(6), s68. https://doi.org/10.25251/skin.6.supp.68